Top Markets
Coin of the day
Aarti Pharmalabs Limited Aarti Pharmalabs Limited

Aarti Pharmalabs Limited

AARTIPHARM
Rang in Aktien #10430
Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and... Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system agent, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, and ophthalmologic medications. It also provides contract development and manufacturing services for drug substance projects. In addition, the company offers intermediates; xanthine derivatives, including caffeine, theophylline anhydrous, aminophylline, etophylline, and theophylline; and acid and allied products, including sulphuric acid, sulphur trioxide, oil, dimethyl sulphate, diethyl sulphate, and sodium vinyl sulfonate. The company was formerly known as Aarti Organics Limited. Aarti Pharmalabs Limited was incorporated in 2019 and is headquartered in Mumbai, India.
Aktienkurs
$9.28
Zuletzt synchronisiert: 2026-08-28
Marktkapitalisierung
$841.31M
Veränderung (1 Tag)
3.34%
Veränderung (1 Jahr)
-2.77%
Land
IN
Handel Aarti Pharmalabs Limited (AARTIPHARM)

Kategorie

Kursverlauf für Aarti Pharmalabs Limited (AARTIPHARM)
Höchster Schlusskurs: $9.24 am 2026-08-01

Niedrigster Schlusskurs: $3.44 am 2023-01-01
Kursverlauf der Aktie von Aarti Pharmalabs Limited von 2023 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 1.40%
2025 12.15%
2024 25.64%
2023 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$171.67 -
DE
$166.36 31.46%
DE
$37.84 25.87%
JP
$222.33 27.49%
CH
$21.19 17.16%
IN